Sovaldi™ (sofosbuvir) and Hepatitis C | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Combining Well Care and Sick Care for Hepatitis C

Back to News Homepage
Next

Price of Pill that Will Likely Cure 90% of Hep C Patients

Sovaldi™ (sofosbuvir) and Hepatitis C

The Editors at Hepatitis Central
December 31, 2013

Print this page

With the approval of Sovaldi™ (sofosbuvir) once a day combination treatment of those with Hepatitis C, genotype 1, 2, 3 and 4, many questions arise. Here we have summarized some of these questions.
What Sovaldi Sofosbuvir Looks Like Pin it on Pinterest

by Editors at Hepatitis-Central.com

With the approval of a new treatment option for those with Hepatitis C genotype 1, 2, 3 and 4 there are bound to be questions. Based on the information provided by Gilead, developer of Sovaldi™, we have provided summaries for many of the questions that are being asked. Learning more about this new combination therapy and discussing this information with your healthcare provider are essential.

Simply click on any of the links below for more details:

28 Comments
Share
Share
Previous

Combining Well Care and Sick Care for Hepatitis C

Back to News Homepage
Next

Price of Pill that Will Likely Cure 90% of Hep C Patients

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.